LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Time Point (hr) Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value Assay Plate Assay Well
MCF 10A-H2B-mCherry Trametinib
0.031623
 41.84 84.90 940 4003 0.2348 0.5411
MN20160318_Q02
F10
MCF 10A-H2B-mCherry Trametinib
0.031623
 43.55 84.90 1163 4287 0.2712 0.5881
MN20160318_Q02
C04
MCF 10A-H2B-mCherry Trametinib
0.031623
 43.55 84.90 1198 4287 0.2794 0.5965
MN20160318_Q02
C04
MCF 10A-H2B-mCherry Trametinib
0.031623
 43.55 84.90 878 4287 0.2048 0.5112
MN20160318_Q02
F10
MCF 10A-H2B-mCherry Trametinib
0.031623
 43.55 84.90 914 4287 0.2132 0.5219
MN20160318_Q02
F10
MCF 10A-H2B-mCherry Trametinib
0.031623
 45.25 84.90 1114 4539 0.2454 0.5658
MN20160318_Q02
C04
MCF 10A-H2B-mCherry Trametinib
0.031623
 45.25 84.90 1139 4539 0.2509 0.5719
MN20160318_Q02
C04
MCF 10A-H2B-mCherry Trametinib
0.031623
 45.25 84.90 908 4539 0.2000 0.5111
MN20160318_Q02
F10
MCF 10A-H2B-mCherry Trametinib
0.031623
 45.25 84.90 940 4539 0.2071 0.5202
MN20160318_Q02
F10
MCF 10A-H2B-mCherry Trametinib
0.031623
 46.95 84.90 1143 4952 0.2308 0.5577
MN20160318_Q02
C04
MCF 10A-H2B-mCherry Trametinib
0.031623
 46.95 84.90 1164 4952 0.2350 0.5625
MN20160318_Q02
C04
MCF 10A-H2B-mCherry Trametinib
0.031623
 46.95 84.90 960 4952 0.1938 0.5120
MN20160318_Q02
F10
MCF 10A-H2B-mCherry Trametinib
0.031623
 46.95 84.90 991 4952 0.2001 0.5203
MN20160318_Q02
F10
MCF 10A-H2B-mCherry Trametinib
0.031623
 48.65 84.90 1173 5328 0.2201 0.5522
MN20160318_Q02
C04
MCF 10A-H2B-mCherry Trametinib
0.031623
 48.65 84.90 1197 5328 0.2246 0.5575
MN20160318_Q02
C04
MCF 10A-H2B-mCherry Trametinib
0.031623
 48.65 84.90 983 5328 0.1845 0.5070
MN20160318_Q02
F10
MCF 10A-H2B-mCherry Trametinib
0.031623
 48.65 84.90 1017 5328 0.1909 0.5156
MN20160318_Q02
F10
MCF 10A-H2B-mCherry Trametinib
0.031623
 50.36 84.90 1191 5651 0.2108 0.5466
MN20160318_Q02
C04
MCF 10A-H2B-mCherry Trametinib
0.031623
 50.36 84.90 1214 5651 0.2148 0.5515
MN20160318_Q02
C04
MCF 10A-H2B-mCherry Trametinib
0.031623
 50.36 84.90 971 5651 0.1718 0.4953
MN20160318_Q02
F10
MCF 10A-H2B-mCherry Trametinib
0.031623
 50.36 84.90 998 5651 0.1766 0.5021
MN20160318_Q02
F10
MCF 10A-H2B-mCherry Trametinib
0.031623
 52.06 84.90 1188 5990 0.1983 0.5368
MN20160318_Q02
C04
MCF 10A-H2B-mCherry Trametinib
0.031623
 52.06 84.90 1216 5990 0.2030 0.5426
MN20160318_Q02
C04
MCF 10A-H2B-mCherry Trametinib
0.031623
 52.06 84.90 1002 5990 0.1673 0.4947
MN20160318_Q02
F10
MCF 10A-H2B-mCherry Trametinib
0.031623
 52.06 84.90 1033 5990 0.1724 0.5022
MN20160318_Q02
F10